206 related articles for article (PubMed ID: 25692672)
21. The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma.
Camerin M; Magaraggia M; Soncin M; Jori G; Moreno M; Chambrier I; Cook MJ; Russell DA
Eur J Cancer; 2010 Jul; 46(10):1910-8. PubMed ID: 20356732
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of peptide-conjugated phthalocyanine photosensitizers with highly hydrophilic modifications.
Li F; Liu Q; Liang Z; Wang J; Pang M; Huang W; Wu W; Hong Z
Org Biomol Chem; 2016 Apr; 14(13):3409-22. PubMed ID: 26956169
[TBL] [Abstract][Full Text] [Related]
23. Methylsulfonyl Zn phthalocyanine: A polyvalent and powerful hydrophobic photosensitizer with a wide spectrum of photodynamic applications.
İşci Ü; Beyreis M; Tortik N; Topal SZ; Glueck M; Ahsen V; Dumoulin F; Kiesslich T; Plaetzer K
Photodiagnosis Photodyn Ther; 2016 Mar; 13():40-47. PubMed ID: 26529064
[TBL] [Abstract][Full Text] [Related]
24. Far-red-absorbing cationic phthalocyanine photosensitizers: synthesis and evaluation of the photodynamic anticancer activity and the mode of cell death induction.
Machacek M; Cidlina A; Novakova V; Svec J; Rudolf E; Miletin M; Kučera R; Simunek T; Zimcik P
J Med Chem; 2015 Feb; 58(4):1736-49. PubMed ID: 25599409
[TBL] [Abstract][Full Text] [Related]
25. Zinc(II) phthalocyanines as photosensitizers for antitumor photodynamic therapy.
Roguin LP; Chiarante N; García Vior MC; Marino J
Int J Biochem Cell Biol; 2019 Sep; 114():105575. PubMed ID: 31362060
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic insight of the photodynamic inactivation of Escherichia coli by a tetracationic zinc(II) phthalocyanine derivative.
Spesia MB; Caminos DA; Pons P; Durantini EN
Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):52-61. PubMed ID: 19447372
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy utilizing liposomal ClAlPc in human melanoma 3D cell cultures.
Barbugli PA; Alves CP; Espreafico EM; Tedesco AC
Exp Dermatol; 2015 Dec; 24(12):970-2. PubMed ID: 26194528
[No Abstract] [Full Text] [Related]
28. Improved photodynamic efficacy of thiophenyl sulfonated zinc phthalocyanine loaded in lipid nano-carriers for hepatocellular carcinoma cancer cells.
Abdel Fadeel D; Al-Toukhy GM; Elsharif AM; Al-Jameel SS; Mohamed HH; Youssef TE
Photodiagnosis Photodyn Ther; 2018 Sep; 23():25-31. PubMed ID: 29870793
[TBL] [Abstract][Full Text] [Related]
29. Serum albumin as a vehicle for zinc phthalocyanine: photodynamic activities in solid tumour models.
Larroque C; Pelegrin A; Van Lier JE
Br J Cancer; 1996 Dec; 74(12):1886-90. PubMed ID: 8980386
[TBL] [Abstract][Full Text] [Related]
30. [Study on the aggregation state of sulfonated phthalimidomethyl zinc phthalocyanine in CEL solution].
Peng Y; Xue J; Huang J; Lin Z; Liu E; Chen N; Huang J
Guang Pu Xue Yu Guang Pu Fen Xi; 2000 Dec; 20(6):875-7. PubMed ID: 12938501
[TBL] [Abstract][Full Text] [Related]
31. Effects of continuous wave and fractionated diode laser on human fibroblast cancer and dermal normal cells by zinc phthalocyanine in photodynamic therapy: A comparative study.
Navaeipour F; Afsharan H; Tajalli H; Mollabashi M; Ranjbari F; Montaseri A; Rashidi MR
J Photochem Photobiol B; 2016 Aug; 161():456-62. PubMed ID: 27318602
[TBL] [Abstract][Full Text] [Related]
32. Tumour-localizing and tumour-photosensitizing properties of zinc(II)-octapentyl-phthalocyanine.
Fabris C; Ometto C; Milanesi C; Jori G; Cook MJ; Russell DA
J Photochem Photobiol B; 1997 Jul; 39(3):279-84. PubMed ID: 9253202
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
34. A novel 10B-enriched carboranyl-containing phthalocyanine as a radio- and photo-sensitising agent for boron neutron capture therapy and photodynamic therapy of tumours: in vitro and in vivo studies.
Friso E; Roncucci G; Dei D; Soncin M; Fabris C; Chiti G; Colautti P; Esposito J; De Nardo L; Riccardo Rossi C; Nitti D; Giuntini F; Borsetto L; Jori G
Photochem Photobiol Sci; 2006 Jan; 5(1):39-50. PubMed ID: 16395426
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and in vitro anticancer activity of zinc(II) phthalocyanines conjugated with coumarin derivatives for dual photodynamic and chemotherapy.
Zhou XQ; Meng LB; Huang Q; Li J; Zheng K; Zhang FL; Liu JY; Xue JP
ChemMedChem; 2015 Feb; 10(2):304-11. PubMed ID: 25369981
[TBL] [Abstract][Full Text] [Related]
36. A non-aggregated silicon(IV) phthalocyanine-lactose conjugate for photodynamic therapy.
Li D; Hu QY; Wang XZ; Li X; Hu JQ; Zheng BY; Ke MR; Huang JD
Bioorg Med Chem Lett; 2020 Jun; 30(12):127164. PubMed ID: 32291134
[TBL] [Abstract][Full Text] [Related]
37. Upconverting crystal/dextran-g-DOPE with high fluorescence stability for simultaneous photodynamic therapy and cell imaging.
Wang H; Wang S; Liu Z; Dong C; Yang J; Gong X; Chang J
Nanotechnology; 2014 Apr; 25(15):155103. PubMed ID: 24651122
[TBL] [Abstract][Full Text] [Related]
38. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use.
Ricci-Júnior E; Marchetti JM
Int J Pharm; 2006 Mar; 310(1-2):187-95. PubMed ID: 16442755
[TBL] [Abstract][Full Text] [Related]
39. A phthalocyanine-peptide conjugate with high in vitro photodynamic activity and enhanced in vivo tumor-retention property.
Ke MR; Yeung SL; Fong WP; Ng DK; Lo PC
Chemistry; 2012 Apr; 18(14):4225-33. PubMed ID: 22378352
[TBL] [Abstract][Full Text] [Related]
40. Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy.
Kim J; Santos OA; Park JH
J Control Release; 2014 Oct; 191():98-104. PubMed ID: 24892975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
